Week 9 HW: Cell Free Systems

Part A: General and Lecturer-Specific Questions

General homework questions

  1. Explain the main advantages of cell-free protein synthesis over traditional in vivo methods, specifically in terms of flexibility and control over experimental variables. Name at least two cases where cell-free expression is more beneficial than cell production.
  • The main advantages of cell-free protein synthesis (CFPS) over traditional in vivo methods include

    • Cell-free systems do not need time-consuming cloning steps
    • Easy manipulation of reaction conditions
    • High-throughput potential
    • Synthesis of difficult to express proteins, such as toxic and transmembrane proteins. In addition, the absence of the cellular membrane allows the synthesis of modified proteins with statistically as well as sitespecifically embedded non-canonical amino acids
    • CFPS) is easily adaptable to the translational requirements of a particular target protein, and the synthesis conditions can be adjusted for a desired subsequent analytical setup
    • Novel automated high-throughput systems are being developed due to the simple handling of liquids and the easy scalability of cell-free reactions
    • Via the removal of the cell membranes and redundant parts of cells, CFPS has provided flexibility in directly dissecting and manipulating the Central Dogma with rapid feedback. non-native chemicals can be introduced directly into the system, allowing greater flexibility in the selection of regulating reagents
    • Such an open nature of the CFPS enables the first-ever programming of modular cellular mimicking processes with active transcription and translation support.
    • ease of use, rapid protein production, and minimal requirements for lab space, equipment, and expertise compared to traditional methods
    • Flexibility: The cell-free expression system can utilize various template DNAs, including PCR products, plasmid DNA, and synthetic DNA, making it suitable for expressing different types of proteins.
  • two cases where cell-free expression is more beneficial than cell production.

    • cell-free protein expression lets researchers incorporate unnatural labels or amino acids into targets of interest, as well as express toxic proteins
    • The accessibility of cell-free reactions enables optimization impossible in cells. Researchers can directly adjust pH, ionic strength, redox potential, metal ion concentrations, or temperature without considering cellular viability. Specific folding catalysts, chaperones, or cofactors can be added at precise concentrations. For disulfide-bonded proteins, the oxidation-reduction balance can be fine-tuned by adding specific ratios of reduced and oxidized glutathione. For metalloproteins, appropriate metal ions can be supplemented. This level of control over the biochemical environment enables optimization of yield and proper folding for challenging targets that fail in standard cellular environments.
  1. Describe the main components of a cell-free expression system and explain the role of each component. There are three fundamental components:
  • Cell-Free Extract: This is the heart of the system, containing the essential cellular components for protein synthesis, such as ribosomes, tRNA, amino acids, and enzymes. The source of the extract can vary, with commonly used ones including E. coli, rabbit reticulocyte, and wheat germ extracts.
  • DNA Template: Researchers provide the genetic information for the desired protein in the form of a DNA template. This template typically contains a promoter sequence to initiate transcription and a coding sequence for the target protein.
  • Energy and Cofactors: Energy sources (e.g., ATP, GTP) and cofactors (e.g., magnesium ions) are supplied to facilitate transcription and translation processes.
  1. Why is energy provision regeneration critical in cell-free systems? Describe a method you could use to ensure continuous ATP supply in your cell-free experiment.

Energy regeneration is critical in cell-free systems because protein synthesis is ATP-intensive, and there is no living metabolism in the reaction mix to continuously replenish ATP as a cell would. Without regeneration, ATP is depleted quickly, protein synthesis slows or stops, and yield drops; stable energy supply is also a major determinant of reaction duration and cost.

Current energy module engineering solutions:

ATP regeneration systems for CFPS

  • using phosphoenolpyruvate (PEP) with pyruvate kinase, creatine phosphate with creatine kinase, or acetyl phosphate with acetate kinase. These systems help maintain energy levels throughout the protein synthesis process, significantly improving yield and duration of the reaction.
    • enzymes like creatine kinase or acetate kinase that regenerate ATP from ADP using high-energy phosphate donors.
    • Secondary energy sources such as phosphoenolpyruvate, creatine phosphate, and acetyl phosphate can be incorporated into cell-free protein synthesis systems to enhance energy availability. These compounds serve as phosphate donors in enzymatic reactions that regenerate ATP.
    • Continuous-exchange cell-free protein synthesis systems: Continuous-exchange cell-free protein synthesis systems involve the continuous supply of energy substrates and removal of inhibitory byproducts during the reaction. These systems utilize specialized reaction chambers with semi-permeable membranes that allow small molecules to diffuse while retaining larger components like ribosomes and enzymes. This approach significantly extends reaction lifetimes and increases protein yields by preventing energy depletion and byproduct accumulation that typically limit batch reactions.

Secondary energy sources and cofactors Beyond primary ATP regeneration, cell-free protein synthesis energy modules incorporate secondary energy sources and essential cofactors. These include NAD+/NADH, NADP+/NADPH, and GTP, which support various biochemical reactions during protein synthesis. Optimized ratios of these cofactors are critical for maintaining redox balance and ensuring efficient translation. Some systems also utilize glucose or maltose with appropriate enzymes to create a continuous energy supply pathway, enhancing the overall efficiency and productivity of the cell-free system.

Engineered extracts for improved energy efficiency Specially engineered cell extracts can significantly improve the energy efficiency of cell-free protein synthesis systems. These extracts are often derived from modified organisms with enhanced metabolic pathways or reduced energy-consuming side reactions. By eliminating competing pathways that deplete energy resources and optimizing the concentration of key enzymes involved in energy metabolism, these engineered extracts can sustain protein synthesis for longer periods with higher yields. Some approaches include genetic modifications to reduce phosphatase activity or enhance glycolytic flux.

  1. Compare prokaryotic versus eukaryotic cell-free expression systems. Choose a protein to produce in each system and explain why.

Prokaryotic cell-free expression systems

The E. coli based CFPS system has redefined the scale standard for protein synthesis. Its core advantage lies in the simplicity and metabolic robustness of the prokaryotic machinery, allowing for high concentration yields in batch and continuous-flow reactions. This platform is the undisputed leader in low-cost, high-throughput synthesis for projects where functional folding (e.g., disulfide bonds or glycosylation) is not a critical factor.

  • Scale Advantage: Capable of producing up to 2 mg/mL of protein, dramatically reducing the cost per gram—similar to Twist’s $0.003/bp DNA synthesis advantage.
  • Speed Metric: Protein production can be completed within 2–4 hours, allowing for parallel synthesis of hundreds of constructs in a single day.
  • Modification Niche: Highly adaptable for specialized labeling, such as efficient incorporation of non-natural amino acids (CFPS for Non-Natural Amino Acid Incorporation Service), due to easy depletion of natural amino acids in the lysate.
  • Limitation: Lacks the machinery (PDI, chaperones, microsomal membranes) for correct folding and processing of complex eukaryotic proteins, often resulting in inclusion bodies or inactive constructs.

Eukaryotic cell-free expression systems

Eukaryotic CFPS systems have specialized in overcoming the functional bottlenecks of prokaryotic expression. By retaining cell-specific endogenous elements—including ribosomes, tRNA pools, and PTM enzymes—they achieve functional integrity for complex targets, aligning with the “clinical-grade accuracy” of GenScript.

Systems based on mammalian cells (HEK293, CHO) are essential for therapeutic protein research.

  • Fidelity Core: The presence of microsomal membranes allows for co-translational or post-translational translocation, critical for synthesizing Cell-Free Membrane Protein Expression and functional antibodies.
  • Key PTM: Capable of performing initial N-glycosylation and forming correct disulfide bonds, reaching a functional correctness standard of 99% for single-chain variable fragments (scFv).
  • Limitation: Production yields are generally 5–10 times lower than E. coli systems, and the lysate preparation process is costly.
  1. How would you design a cell-free experiment to optimize the expression of a membrane protein? Discuss the challenges and how you would address them in your setup.

  2. Imagine you observe a low yield of your target protein in a cell-free system. Describe three possible reasons for this and suggest a troubleshooting strategy for each.

References

  1. https://pubmed.ncbi.nlm.nih.gov/26478227/
  2. https://www.sciencedirect.com/science/article/pii/S200103702300185X
  3. https://www.cytion.com/us/About-Cytion/Knowledge-Hub/Articles-Updates/Cell-Free-Systems-for-Protein-Production-Advantages-Over-Living-Cells/
  4. https://www.idtdna.com/pages/applications/cell-free-protein-synthesis
  5. https://www.cusabio.com/cell-free-expression-system.html
  6. https://eureka.patsnap.com/report-energy-module-engineering-for-sustainable-cell-free-protein-synthesis
  7. https://www.biosynsis.com/a-comparative-guide-prokaryotic-vs-eukaryotic-cell-free-expression-systems-for-eukaryotic-proteins.html